Clinical Trials Logo
  1. Home
  2. Chronic Gastritis
  3. NCT04341454

Study to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Chronic Gastritis Clinical Trial

Official title:
A Multi-Center, Double-blind, Randomized, Placebo-controlled, Parallel-Group, Phase 3, Therapeutic Confirmatory Clinical Trial to Evaluate the Efficacy and Safety of DWP14012 in Patients With Acute or Chronic Gastritis

Clinical Trial Summary

The purpose of study is to confirm the efficacy of DWP14012 X mg QD, DWP14012 Y mg BID compared to placebo in patients with Acute or Chronic Gastritis

Clinical Trial Description

This study was designed as a multi-center, randomized, double-blind, placebo-controlled, parallel-group, phase 3 study to assess the efficacy and safety of oral administration of DWP14012 X mg QD, Y mg BID and placebo for 2 weeks in patients with acute and chronic gastritis. ;

Study Design

Related Conditions & MeSH terms

Clinical Trial Details
NCT number NCT04341454
Study type Interventional
Source Daewoong Pharmaceutical Co. LTD.
Contact
Status Completed
Phase Phase 3
Start date June 2, 2020
Completion date September 16, 2021
View Details
See also
  Status Clinical Trial Phase
Completed NCT04066530 - A Study to Evaluate the Efficacy and Safety of AD-203 Phase 3
Recruiting NCT05048069 - Post-Marketing Surveillance of Safety and Effectiveness of Mucosta®SR Tab.
Completed NCT01817556 - A Study to Evaluate the Efficacy and of Stillen Tab. and to Demonstrate the Non-inferiority of Stillen Tab. Phase 4
Recruiting NCT01813812 - A Study to Evaluate the Efficacy and Safety of DA-6034 and to Demonstrate the Non-inferiority of DA-6034 Phase 3
Completed NCT00996788 - Anti Free Radical & Anti Inflammatory Effect & Safety of Rebamipide in Chronic Gastritis Phase 3
Enrolling by invitation NCT05021029 - A Study of Pre-Malignant Gastric Conditions
Completed NCT05073614 - Evaluation of Immunohistochemical Expression of Heparanase in Helicobacter Pylori-Associated Chronic Gastritis N/A
Completed NCT04697186 - Helicobacter Pylori Eradication With Berberine Plus Amoxicillin Triple Therapy Versus Bismuth-containing Quadruple Therapy Phase 4
Recruiting NCT00455806 - Esomeprazole, Moxifloxacin and Amoxicilin for Rescue Therapy of Helicobacter Pylori Infection Phase 3
Recruiting NCT05666531 - Research on Innovative Diagnosis and Treatment System of Syndrome Differentiation of Zang-fu Viscera and Effectiveness Evaluation Based on Inter-Arm Blood Pressure Measured Simultaneously
Completed NCT03847753 - Exploring the Comorbidity Between Mental Disorders and General Medical Conditions
Completed NCT04189705 - A Study to Evaluate the Efficacy and Safety of MCT-SR in Patients With Gastritis Phase 3
Completed NCT05014334 - Study on The Efficacy and Safety of Berberine-containing Triple Therapy in Helicobacter Pylori First-Line Eradication Phase 4
Completed NCT02356679 - Efficacy and Safety of Eupasidin-s Tab.(EUPASIDIN-S) in Gastritis Patients Phase 4
Completed NCT02219529 - Magnetic-controlled Capsule Endoscopy vs. Gastroscopy for Detection of Gastric Diseases Phase 3
Completed NCT03609892 - Helicobacter Rescue Therapy With Berberine Plus Amoxicillin Quadruple Therapy Versus Tetracycline Plus Furazolidone Quadruple Therapy Phase 4
Unknown status NCT02282670 - A Study to Evaluate the Efficacy and Safety of DA-5204 Phase 3
Completed NCT01119768 - Esomeprazole Treatment Co-diagnosed Non Erosive Reflux Disease (NERD) and Chronic Gastritis Patients Phase 4
Completed NCT02658864 - Pharmacokinetic Properties and Effect of Food on Pharmacokinetic Properties of the Oral Lafutidine Tablets Phase 1